Cheryl Gault Biography and Net Worth

Cheryl has over 20 years of biopharma industry experience. Her experience includes corporate strategy, corporate and business development, portfolio strategy, new product planning, marketing, sales, launch and commercial strategy in various therapeutic areas including neurology, gastroenterology, rheumatology, and orthopedics. Ms. Gault served as the Chief Operating Officer at Cyclerion Therapeutics where she played a leadership role in delivering clinical data readouts for several novel molecules in large and orphan indications and successfully completing critical transactions to increase shareholder value. Ms. Gault played a central role while at Ironwood in the successful launch of LINZESS^®, the $1B market leader in IBS. Prior to that, she was at Genzyme Corporation in a variety of sales and marketing roles in the biosurgery division, including a leadership role in the launch of Synvisc-ONE, an injectable for the treatment of osteoarthritis. Cheryl brings a unique commercial perspective to our drug development team. She earned a B.S. in marketing from Boston College.